A Study in Healthy Male Subjects to Investigate the Comparability of Pharmacokinetics of the Fixed-Dose Combination of Pertuzumab and Trastuzumab Administered Subcutaneously Using a Handheld Syringe or Using the On-Body Delivery System
Clinical trial NCT05275010 · COMPLETED
Trial details
- NCT number
- NCT05275010
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-30
- Primary completion
- 2023-05-14
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.